Cost minimization analysis of beta-blocker at the time of CT imaging for suspected of coronary heart disease in Japan (Englisch)
Freier Zugriff
- Neue Suche nach: Igarashi, Ataru
- Neue Suche nach: Fujito, Kaori
- Neue Suche nach: Hirano, Masaharu
- Neue Suche nach: Fukuda, Takashi
- Neue Suche nach: Igarashi, Ataru
- Neue Suche nach: Fujito, Kaori
- Neue Suche nach: Hirano, Masaharu
- Neue Suche nach: Fukuda, Takashi
In:
Journal of Medical Economics
;
17
, 2
;
142-147
;
2014
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:Cost minimization analysis of beta-blocker at the time of CT imaging for suspected of coronary heart disease in Japan
-
Beteiligte:Igarashi, Ataru ( Autor:in ) / Fujito, Kaori ( Autor:in ) / Hirano, Masaharu ( Autor:in ) / Fukuda, Takashi ( Autor:in )
-
Erschienen in:Journal of Medical Economics ; 17, 2 ; 142-147
-
Verlag:
- Neue Suche nach: Taylor & Francis
-
Erscheinungsdatum:01.02.2014
-
Format / Umfang:6 pages
-
ISSN:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Englisch
-
Schlagwörter:
-
Datenquelle:
Inhaltsverzeichnis – Band 17, Ausgabe 2
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 89
-
Economic benefits of adequate molecular monitoring in patients with chronic myelogenous leukemiaGuérin, Annie / Chen, Lei / Dea, Katherine / Wu, Eric Q. / Goldberg, Stuart L. et al. | 2014
- 99
-
Economic outcomes of sequences which include monoclonal antibodies against vascular endothelial growth factor and/or epidermal growth factor receptor for the treatment of unresectable metastatic colorectal cancerRautenberg, T. / Siebert, U. / Arnold, D. / Bennouna, J. / Kubicka, S. / Walzer, S. / Ngoh, C. et al. | 2014
- 111
-
Bendamustine-rituximab: a cost-utility analysis in first-line treatment of indolent non-Hodgkin’s lymphoma in England and WalesDewilde, Sarah / Woods, Beth / Castaigne, Jean-Gabriel / Parker, Christopher / Dunlop, William et al. | 2014
- 125
-
An incidence model of the cost of advanced prostate cancer in SpainHart, W. M. / Nazir, J. / Baskin-Bey, E. et al. | 2014
- 132
-
Cost effectiveness analysis of a next generation risk assessment score for cardiovascular diseaseHytopoulos, Evangelos / Lee, Martin L. / Beggs, Michael / French, Cynthia / Tong, Kuo Bianchini et al. | 2014
- 142
-
Cost minimization analysis of beta-blocker at the time of CT imaging for suspected of coronary heart disease in JapanIgarashi, Ataru / Fujito, Kaori / Hirano, Masaharu / Fukuda, Takashi et al. | 2014
- 148
-
Healthcare costs among patients with chronic constipation: a retrospective claims analysis in a commercially insured populationCai, Qian / Buono, Jessica L. / Spalding, William M. / Sarocco, Phil / Tan, Hiangkiat / Stephenson, Judith J. / Carson, Robyn T. / Doshi, Jalpa A. et al. | 2014
- 159
-
Cost and time savings from a rapid access model of care using transient elastography to screen and triage patients with chronic Hepatitis C infectionWhitty, Jennifer A. / Tallis, Caroline / Nguyen, Kim-Huong / Scuffham, Paul A. / Crosland, Paul / Hewson, Kaye / Pai Mangalore, Rehka / Black, Marrianne / Holtmann, Gerald et al. | 2014